Picture of Tanvex Biopharma logo

6541 Tanvex Biopharma Share Price

0.000.00%
tw flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Momentum

Relative Strength (%)
1m-22.99%
3m-25.5%
6m-27.71%
1yr-46.15%
Volume Change (%)
10d/3m-21.12%
Price vs... (%)
52w High-47.16%
50d MA-17.89%
200d MA-25.52%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-67.63%
Return on Equity-128.71%
Operating Margin-3441.36%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Tanvex Biopharma EPS forecast chart

Profile Summary

Tanvex BioPharma, Inc. is a Cayman Islands-based biopharmaceutical company focused on the biosimilar market. The company has expertise in areas, including strain and cell-line development in both microbial and mammalian systems, cell culture, protein purification, process scale-up, drug substance and product manufacturing, and others. The Company’s product pipeline includes Neupogen (TX-01), Herceptin (TX-05), Neulasta (TX-04), Avastin (TX-16), Perjeta (TX-52), and others. The Company offers a vertically integrated manufacturing platform for biopharmaceuticals. The Company is developing and delivering biologic and biosimilar drugs to people.

Directors

Last Annual
December 31st, 2022
Last Interim
September 30th, 2023
Incorporated
May 8th, 2013
Public Since
August 13th, 2015
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
tw flag iconTaiwan Stock Exchange
Shares in Issue
133,962,867

6541 Share Price Performance

Upcoming Events for 6541

March 2024 Tanvex BioPharma Inc Corporate Sales Release

April 2024 Tanvex BioPharma Inc Corporate Sales Release

Q1 2024 Tanvex BioPharma Inc Earnings Release

May 2024 Tanvex BioPharma Inc Corporate Sales Release

Tanvex BioPharma Inc Annual Shareholders Meeting

June 2024 Tanvex BioPharma Inc Corporate Sales Release

Q2 2024 Tanvex BioPharma Inc Earnings Release

July 2024 Tanvex BioPharma Inc Corporate Sales Release

August 2024 Tanvex BioPharma Inc Corporate Sales Release

Similar to 6541

Picture of Abnova Taiwan logo

Abnova Taiwan

tw flag iconTaiwan Stock Exchange

Picture of Applied BioCode logo

Applied BioCode

tw flag iconTaiwan Stock Exchange

Picture of Energenesis Biomedical Co logo

Energenesis Biomedical Co

tw flag iconTaiwan Stock Exchange

Picture of Kim Forest Enterprise Co logo

Kim Forest Enterprise Co

tw flag iconTaiwan Stock Exchange

Picture of PHARMAESSENTIA logo

PHARMAESSENTIA

tw flag iconTaiwan Stock Exchange

FAQ